-
Product Insights
NewLikelihood of Approval Analysis for Poxviridae Infections
Overview How likely is it that the drugs in Poxviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Poxviridae Infections Overview Poxviridae is a family of double-stranded DNA viruses. Poxviruses...
-
Product Insights
NewLikelihood of Approval Analysis for Orthomyxoviridae Infections
Overview How likely is it that the drugs in Orthomyxoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orthomyxoviridae Infections Overview The family Orthomyxoviridae is defined by viruses that have...
-
Company Insights
Innovation and Patenting activity of BGI Genomics Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BGI Genomics Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval Analysis for Mutational Disorders
Overview How likely is it that the drugs in Mutational Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mutational Disorders Overview Mutational disorders, alternatively termed genetic or genomic disorders, stem...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azercabtagene Zapreleucel in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azercabtagene Zapreleucel in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azercabtagene Zapreleucel in Diffuse Large B-Cell Lymphoma Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azercabtagene Zapreleucel in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azercabtagene Zapreleucel in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azercabtagene Zapreleucel in Mantle Cell Lymphoma Drug Details: Azercabtagene...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azercabtagene Zapreleucel in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azercabtagene Zapreleucel in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azercabtagene Zapreleucel in Follicular Lymphoma Drug Details: Azercabtagene zapreleucel (PBCAR-0191)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azercabtagene Zapreleucel in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azercabtagene Zapreleucel in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azercabtagene Zapreleucel in Primary Mediastinal B-Cell Lymphoma Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Azercabtagene Zapreleucel in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Azercabtagene Zapreleucel in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Azercabtagene Zapreleucel in Non-Hodgkin Lymphoma Drug Details: Azercabtagene zapreleucel (PBCAR-0191)...
-
Product Insights
NewLikelihood of Approval Analysis for Paramyxoviridae Infections
Overview How likely is it that the drugs in Paramyxoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paramyxoviridae Infections Overview The Paramyxoviridae family belongs to the order Mononegavirales, the...